WEKO3
アイテム
{"_buckets": {"deposit": "c092d48f-d522-41b4-8574-c3661bf85f65"}, "_deposit": {"id": "2000285", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "2000285"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:02000285", "sets": []}, "author_link": [], "item_14_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-03-31", "bibliographicIssueDateType": "Issued"}}]}, "item_14_date_granted_8": {"attribute_name": "学位授与年月日", "attribute_value_mlt": [{"subitem_dategranted": "2021-03-31"}]}, "item_14_degree_grantor_10": {"attribute_name": "学位授与機関", "attribute_value_mlt": [{"subitem_degreegrantor": [{"subitem_degreegrantor_name": "信州大学(Shinshu university)"}], "subitem_degreegrantor_identifier": [{"subitem_degreegrantor_identifier_name": "13601", "subitem_degreegrantor_identifier_scheme": "kakenhi"}]}]}, "item_14_degree_name_9": {"attribute_name": "学位名", "attribute_value_mlt": [{"subitem_degreename": "博士(医学)"}]}, "item_14_description_26": {"attribute_name": "内容記述", "attribute_value_mlt": [{"subitem_description": "雑誌に発表。 / Thoracic Cancer 10(9) :1805-1811(2020); doi:10.1111/1759-7714.13150. © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley \u0026 Sons Australia, Ltd 1805 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited and is not used for commercial purposes.", "subitem_description_type": "Other"}]}, "item_14_description_37": {"attribute_name": "資源タイプ(コンテンツの種類)", "attribute_value_mlt": [{"subitem_description": "Thesis", "subitem_description_type": "Other"}]}, "item_14_description_5": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "曽根原 圭. The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究). 信州大学, 2021, 博士論文. 博士(医学), 甲第1230号, 令和03年03月31日授与.", "subitem_description_language": "ja", "subitem_description_type": "Other"}]}, "item_14_dissertation_number_7": {"attribute_name": "学位授与番号", "attribute_value_mlt": [{"subitem_dissertationnumber": "13601甲第1230号"}]}, "item_14_publisher_4": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "信州大学"}]}, "item_14_relation_54": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "31350820"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://pubmed.ncbi.nlm.nih.gov/31350820/", "subitem_relation_type_select": "PMID"}}]}, "item_14_relation_55": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1111/1759-7714.13150"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1111/1759-7714.13150", "subitem_relation_type_select": "DOI"}}]}, "item_14_select_71": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "ETD"}]}, "item_14_text_11": {"attribute_name": "学位の区分", "attribute_value_mlt": [{"subitem_text_value": "doctoral"}]}, "item_14_text_12": {"attribute_name": "学位の分野", "attribute_value_mlt": [{"subitem_text_value": "医学"}]}, "item_14_text_13": {"attribute_name": "学位の報告番号", "attribute_value_mlt": [{"subitem_text_value": "甲第1230号"}]}, "item_1627890986942": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_be7fb7dd8ff6fe43", "subitem_version_type": "NA"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "曽根原, 圭", "creatorNameLang": "ja"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-06-28"}], "download_preview_message": "", "file_order": 0, "filename": "17MH020A_yoshi.pdf", "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 0, "url": {"label": "内容の要旨", "url": "https://soar-ir.repo.nii.ac.jp/record/2000285/files/17MH020A_yoshi.pdf"}, "version_id": "9928b533-4742-4435-8480-9023cd3ed598"}, {"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-06-28"}], "download_preview_message": "", "file_order": 1, "filename": "17MH020A_shinsa.pdf", "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 0, "url": {"label": "審査結果の要旨", "url": "https://soar-ir.repo.nii.ac.jp/record/2000285/files/17MH020A_shinsa.pdf"}, "version_id": "4615a844-528c-45e5-8be3-e762f26b794a"}, {"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-06-28"}], "download_preview_message": "", "file_order": 2, "filename": "17MH020A_ronbun.pdf", "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 0, "url": {"label": "博士論文の全文", "objectType": "fulltext", "url": "https://soar-ir.repo.nii.ac.jp/record/2000285/files/17MH020A_ronbun.pdf"}, "version_id": "518bba73-22d8-492e-868e-22e8d35bf6b9"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "doctoral thesis", "resourceuri": "http://purl.org/coar/resource_type/c_db06"}]}, "item_title": "The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究)", "subitem_title_language": "en"}]}, "item_type_id": "14", "owner": "1", "path": ["849"], "permalink_uri": "http://hdl.handle.net/10091/0002000285", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2021-06-28"}, "publish_date": "2021-06-28", "publish_status": "0", "recid": "2000285", "relation": {}, "relation_version_is_last": true, "title": ["The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究)"], "weko_shared_id": -1}
The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究)
http://hdl.handle.net/10091/0002000285
http://hdl.handle.net/10091/0002000285c7aeb19e-464d-4b92-bb24-a4d85a81706b
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
|
![]() |
|
|
![]() |
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||||
---|---|---|---|---|---|---|---|---|
公開日 | 2021-06-28 | |||||||
タイトル | ||||||||
言語 | en | |||||||
タイトル | The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究) | |||||||
言語 | ||||||||
言語 | eng | |||||||
資源タイプ | ||||||||
資源 | http://purl.org/coar/resource_type/c_db06 | |||||||
タイプ | doctoral thesis | |||||||
アクセス権 | ||||||||
アクセス権 | open access | |||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||
著者 |
曽根原, 圭
× 曽根原, 圭
|
|||||||
出版者 | ||||||||
出版者 | 信州大学 | |||||||
引用 | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | 曽根原 圭. The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute (再発進展型小細胞肺癌の症例に対する3次化学療法としてのアムルビシンの有効性(単施設における後方視的な研究). 信州大学, 2021, 博士論文. 博士(医学), 甲第1230号, 令和03年03月31日授与. | |||||||
言語 | ja | |||||||
書誌情報 |
発行日 2021-03-31 |
|||||||
学位授与番号 | ||||||||
学位授与番号 | 13601甲第1230号 | |||||||
学位授与年月日 | ||||||||
学位授与年月日 | 2021-03-31 | |||||||
学位名 | ||||||||
学位名 | 博士(医学) | |||||||
学位授与機関 | ||||||||
学位授与機関識別子Scheme | kakenhi | |||||||
学位授与機関識別子 | 13601 | |||||||
学位授与機関名 | 信州大学(Shinshu university) | |||||||
学位の区分 | ||||||||
doctoral | ||||||||
学位の分野 | ||||||||
医学 | ||||||||
学位の報告番号 | ||||||||
甲第1230号 | ||||||||
内容記述 | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | 雑誌に発表。 / Thoracic Cancer 10(9) :1805-1811(2020); doi:10.1111/1759-7714.13150. © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd 1805 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited and is not used for commercial purposes. | |||||||
資源タイプ(コンテンツの種類) | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | Thesis | |||||||
PubMed | ||||||||
識別子タイプ | PMID | |||||||
関連識別子 | https://pubmed.ncbi.nlm.nih.gov/31350820/ | |||||||
関連名称 | 31350820 | |||||||
DOI | ||||||||
識別子タイプ | DOI | |||||||
関連識別子 | https://doi.org/10.1111/1759-7714.13150 | |||||||
関連名称 | 10.1111/1759-7714.13150 | |||||||
出版タイプ | ||||||||
出版タイプ | NA | |||||||
出版タイプResource | http://purl.org/coar/version/c_be7fb7dd8ff6fe43 |